Department of Clinical Medicine, Hemodialysis Unit, Umberto I, Polyclinic of Rome, Sapienza University of Rome, Rome, Italy.
Department of Gynecology, Obstetrics and Urological Sciences, Hemodialysis Unit, Umberto I, Polyclinic of Rome, Sapienza University of Rome, Rome, Italy.
Cardiorenal Med. 2015 Feb;5(1):20-30. doi: 10.1159/000369588. Epub 2014 Dec 13.
Mortality in dialysis patients is higher than in the general population, and cardiovascular disease represents the leading cause of death. Hypertension and volume overload are important risk factors for the development of left ventricular hypertrophy (LVH) in hemodialysis (HD) and peritoneal dialysis (PD) patients. Other factors are mainly represented by hyperparathyroidism, vascular calcification, arterial stiffness and inflammation. The aim of this study was to compare blood pressure (BP) and metabolic parameters with cardiovascular changes [cardiothoracic ratio (CTR), aortic arch calcification (AAC) and LV mass index (LVMI)] between PD and HD patients.
45 patients (23 HD and 22 PD patients) were enrolled. BP measurements, echocardiography and chest X-ray were performed in each patient to determine the LVMI and to evaluate the CTR and AAC. Inflammatory indexes, intact parathyroid hormone (iPTH) and arterial blood gas analysis were also evaluated.
LVMI was higher in PD than HD patients (139 ŷ 19 vs. 104 ŷ 22; p = 0.04). In PD patients, a significant correlation between iPTH, C-reactive protein and the presence of LVH was observed (r = 0.70, p = 0.04; r = 0.70, p = 0.03, respectively). The CTR was increased in PD patients as compared to HD patients, while no significant differences in cardiac calcifications were determined.
Our data indicate that HD patients present more effective BP control than PD patients. Adequate fluid and metabolic control are necessary to assess the adequacy of BP, which is strongly correlated with the increase in LVMI and with the increased CTR in dialysis patients. PD is a home therapy and allows a better quality of life, but PD patients may present a further increased cardiovascular risk if not adequately monitored.
透析患者的死亡率高于普通人群,心血管疾病是导致其死亡的主要原因。高血压和容量超负荷是血液透析(HD)和腹膜透析(PD)患者左心室肥厚(LVH)发展的重要危险因素。其他因素主要包括甲状旁腺功能亢进、血管钙化、动脉僵硬和炎症。本研究旨在比较 PD 和 HD 患者的血压(BP)和代谢参数与心血管变化[心胸比(CTR)、主动脉弓钙化(AAC)和左心室质量指数(LVMI)]。
共纳入 45 名患者(23 名 HD 患者和 22 名 PD 患者)。对每位患者进行血压测量、超声心动图和胸部 X 线检查,以确定 LVMI,并评估 CTR 和 AAC。还评估了炎症指标、全段甲状旁腺激素(iPTH)和动脉血气分析。
PD 患者的 LVMI 高于 HD 患者(139 ± 19 比 104 ± 22;p = 0.04)。在 PD 患者中,iPTH、C 反应蛋白与 LVH 的存在之间存在显著相关性(r = 0.70,p = 0.04;r = 0.70,p = 0.03)。与 HD 患者相比,PD 患者的 CTR 增加,但心脏钙化无显著差异。
我们的数据表明,HD 患者的血压控制效果优于 PD 患者。为了评估血压的充分性,需要进行适当的液体和代谢控制,这与 LVMI 的增加以及透析患者 CTR 的增加密切相关。PD 是一种家庭治疗方法,可以提高生活质量,但如果不能得到充分监测,PD 患者可能会面临更高的心血管风险。